Compliance & Validation — Documented
ISO 27001
Generis
CARA Life Sciences Platform for regulatory information management and controlled content across regulatory, quality, and clinical.
Generis, founded in 1998 and headquartered in London, United Kingdom, develops the CARA Life Sciences Platform — a content and information management platform used by pharmaceutical companies for regulatory information management, submission document management, and related quality and clinical content workflows. The privately held company publishes an ISO/IEC 27001:2022 certificate for its information security management system. Generative-AI capabilities are newer additions and should be evaluated separately from the established document management core.
- Headquarters
- London, United Kingdom
- Founded
- 1998
- Compliance
- ISO 27001
- Deployment options
- cloud
- Website
- https://www.generiscorp.com
- https://www.linkedin.com/company/generis-enterprise-technology
Categories
AI Use Cases
- Regulatory Submission Authoring
Vendor Scorecard
64% — Partial coverage. Coverage score — how completely Atlas documents Generis across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Deployment & Hosting — Documented
cloud
Pricing Transparency — Not documented by Atlas
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Implementation & Onboarding — Not documented by Atlas
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Organization & Role Fit — Documented
Mid-Size Biotech, Large Pharma, Top 20 Pharma, Regulatory Affairs, IT / Digital
Solution Scope — Documented
Regulatory Submission Authoring
Company Viability — Partially documented
Private, Founded 1998
Always ask the vendor
Not captured in Atlas data — confirm directly. Excluded from the score above.
Data Rights & IP
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Model Credibility & Explainability
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?
Questions to Ask This Vendor
- Which RIM and submission management capabilities are in production at reference customers our size?
- How does migration from our current document management system work in practice?
- Which AI features are generally available versus early access?
- How is platform validation documentation delivered for our GxP processes?